DE69725587D1 - Verwendung von wnt polypeptiden - Google Patents
Verwendung von wnt polypeptidenInfo
- Publication number
- DE69725587D1 DE69725587D1 DE69725587T DE69725587T DE69725587D1 DE 69725587 D1 DE69725587 D1 DE 69725587D1 DE 69725587 T DE69725587 T DE 69725587T DE 69725587 T DE69725587 T DE 69725587T DE 69725587 D1 DE69725587 D1 DE 69725587D1
- Authority
- DE
- Germany
- Prior art keywords
- wnt polypeptides
- wnt
- polypeptides
- hematopoiesis
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US696566 | 1996-08-16 | ||
US08/696,566 US5851984A (en) | 1996-08-16 | 1996-08-16 | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
PCT/US1997/013910 WO1998006747A2 (en) | 1996-08-16 | 1997-08-07 | USE OF WNT POLYPEPTIDES |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69725587D1 true DE69725587D1 (de) | 2003-11-20 |
DE69725587T2 DE69725587T2 (de) | 2004-07-29 |
Family
ID=24797608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69725587T Expired - Lifetime DE69725587T2 (de) | 1996-08-16 | 1997-08-07 | Verwendung von wnt polypeptiden |
Country Status (9)
Country | Link |
---|---|
US (1) | US5851984A (de) |
EP (1) | EP0918794B1 (de) |
JP (1) | JP3759623B2 (de) |
AT (1) | ATE252113T1 (de) |
AU (1) | AU721947B2 (de) |
DE (1) | DE69725587T2 (de) |
ES (1) | ES2208943T3 (de) |
IL (2) | IL128129A0 (de) |
WO (1) | WO1998006747A2 (de) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159462A (en) * | 1996-08-16 | 2000-12-12 | Genentech, Inc. | Uses of Wnt polypeptides |
WO2000018885A1 (en) | 1998-09-29 | 2000-04-06 | Gamida Cell Ltd. | Methods of controlling proliferation and differentiation of stem and progenitor cells |
DE69920002T2 (de) * | 1998-04-28 | 2005-09-22 | Applied Research Systems Ars Holding N.V. | Konjugate aus polyole und beta-interferon |
US6485972B1 (en) * | 1998-10-15 | 2002-11-26 | President And Fellows Of Harvard College | WNT signalling in reproductive organs |
BR9905867A (pt) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula |
US20030104561A1 (en) * | 1999-02-09 | 2003-06-05 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2000061630A1 (en) * | 1999-04-08 | 2000-10-19 | President And Fellows Of Harvard College | Induction of kidney tubule formation |
US20020034772A1 (en) * | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
CA2396576A1 (en) * | 2000-01-18 | 2001-07-26 | Tannishtha Reya | Expansion of stem and progenitor cells by beta-catenin |
US6653448B1 (en) * | 2000-03-29 | 2003-11-25 | Curagen Corporation | Wnt-7B-like polypeptides and nucleic acids encoding same |
US6600018B1 (en) * | 2000-04-10 | 2003-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
MXPA03000190A (es) * | 2000-06-26 | 2004-09-13 | Rxkinetix Inc | Composicion para el suministro del factor de crecimiento hamtopoyetico. |
DE60107022T2 (de) | 2000-07-24 | 2005-11-24 | Health Research Inc. | Verfahren zur Detektion von Prostata-spezifischem Membran-Antigen in Serum |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20030032179A1 (en) | 2000-12-06 | 2003-02-13 | Hariri Robert J. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
AU2002220209B2 (en) | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
JP4029041B2 (ja) * | 2001-01-10 | 2008-01-09 | アメリカ合衆国 | sFRPおよびsFRPと相互作用するペプチドモチーフならびにそれらの使用法 |
KR101012952B1 (ko) | 2001-02-14 | 2011-02-08 | 안트로제네시스 코포레이션 | 산후 포유류의 태반, 이의 용도 및 태반 줄기세포 |
US7087586B2 (en) * | 2001-04-24 | 2006-08-08 | Bioniche Life Sciences, Inc. | Oligonucleotide compositions and their use to induce differentiation of cells |
US7713526B2 (en) * | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US20030044409A1 (en) * | 2001-05-01 | 2003-03-06 | Carson Dennis A. | Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
US7682607B2 (en) * | 2001-05-01 | 2010-03-23 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US7101693B2 (en) * | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
IL152904A0 (en) | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
WO2003062404A1 (en) | 2002-01-25 | 2003-07-31 | Gamida-Cell Ltd. | Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
DE10209821A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
CA2479056A1 (en) * | 2002-03-11 | 2003-09-18 | Reprocell Inc. | Protein sustaining undifferentiated stem cells as such |
DE10212867B4 (de) * | 2002-03-22 | 2005-07-21 | Hans Prof. Dr. Wolf | Verwendung Harnstoff-adjuvierter Polypeptide zur Diagnose, Prophylaxe und Therapie |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US7378232B2 (en) * | 2002-05-09 | 2008-05-27 | New York University | Assay for melanogenesis |
AU2003304106C1 (en) | 2002-05-17 | 2010-10-28 | Mount Sinai School Of Medicine Of New York University | Mesoderm and definitive endoderm cell populations |
JP2005528105A (ja) * | 2002-05-30 | 2005-09-22 | セルジーン・コーポレーション | 細胞分化をモジュレートするため、並びに骨髄増殖性疾患及び骨髄異形成症候群を治療するためのjnk又はmkk阻害剤の使用方法 |
US7217568B2 (en) * | 2002-05-31 | 2007-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of identifying and isolating stem cells and cancer stem cells |
WO2004024776A1 (en) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
WO2004032838A2 (en) * | 2002-10-04 | 2004-04-22 | The Regents Of The University Of California | Methods for treating cancer by inhibiting wnt signaling |
AU2003274748A1 (en) * | 2002-11-08 | 2004-06-07 | Reprocell Inc. | Expansion agents for stem cells |
AU2003293013A1 (en) * | 2002-11-21 | 2004-06-18 | University Of Massachusets | Diagnosing and treating hematopoietic cancers |
KR101042448B1 (ko) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법 |
EP1567008A4 (de) * | 2002-12-06 | 2008-10-08 | Univ Leland Stanford Junior | Schutz von stammzellen gegen cytotoxischesubstanzen durch modulation der beta-catenin-signalleitungswege |
US7803783B2 (en) * | 2002-12-06 | 2010-09-28 | The Board Of Trustees Of The Leland Stanford Junior University | Use of WNT inhibitors to augment therapeutic index of chemotherapy |
EP1577380B1 (de) * | 2002-12-27 | 2013-06-05 | Mitsubishi Heavy Industries, Ltd. | Verfahren zur kultivierung von multipotenten stammzellen und kulturvorrichtung dafür |
WO2004091647A1 (en) | 2003-04-07 | 2004-10-28 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions of active wnt protein |
US20050043260A1 (en) * | 2003-04-21 | 2005-02-24 | Baylor College Of Medicine | Wnt as a factor for cardiac myogenesis |
WO2004113380A1 (en) * | 2003-06-25 | 2004-12-29 | Ottawa Health Research Institute | Use of cardiotrophin to modulate stem cell proliferation |
JP4750697B2 (ja) * | 2003-06-25 | 2011-08-17 | オタワ ヘルス リサーチ インスティテュート | 幹細胞の成長及び分化を調節する方法及び組成物 |
US7939058B2 (en) * | 2003-07-03 | 2011-05-10 | University Of Southern California | Uses of IL-12 in hematopoiesis |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
CN102302787A (zh) * | 2004-03-11 | 2012-01-04 | 费森尤斯卡比德国有限公司 | 羟烷基淀粉和蛋白质的接合物 |
TWI417303B (zh) | 2004-03-11 | 2013-12-01 | Fresenius Kabi De Gmbh | 經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物 |
US20060040883A1 (en) * | 2004-05-14 | 2006-02-23 | The Regents Of The University Of California | Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
WO2006030442A2 (en) | 2004-09-16 | 2006-03-23 | Gamida-Cell Ltd. | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
WO2006034602A1 (fr) * | 2004-09-28 | 2006-04-06 | Beijing Institute Of Transfusion Medicine | Procedes pour la proliferation de cellules souches/hematopoietiques in vitro |
ES2667169T3 (es) | 2004-10-19 | 2018-05-09 | Regeneron Pharmaceuticals, Inc. | Método para generar un animal no humano homocigótico para una modificación genética |
AU2012200875B2 (en) * | 2004-12-30 | 2012-08-30 | Robarts Research Institute | Methods for regulation of stem cells |
US7850960B2 (en) * | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
AU2006222187A1 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
WO2007030658A2 (en) * | 2005-09-08 | 2007-03-15 | Children's Hospital Medical Center | Compositions useful for and methods of modulating angiogenesis |
EP1762250A1 (de) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen |
ES2452595T3 (es) | 2005-10-13 | 2014-04-02 | Anthrogenesis Corporation | Inmunomodulación usando células madre de la placenta |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
KR20210122908A (ko) | 2005-12-29 | 2021-10-12 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
AU2006332679A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
DK2120977T3 (da) | 2007-02-12 | 2013-08-12 | Anthrogenesis Corp | Behandling af inflammatoriske sygdomme under anvendelse af placenta-stamceller |
EP2129775A1 (de) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocyten und chondrocyten aus adhärenten plazentastammzellen sowie cd34+, cd45- plazentastammzellenangereicherte zellpopulationen |
US20080226707A1 (en) * | 2007-03-05 | 2008-09-18 | Jill Helms | WNT compositions and methods of use thereof |
EP2148569B1 (de) * | 2007-04-23 | 2014-07-16 | Stowers Institute for Medical Research | Verfahren und zusammensetzungen für die selbsterneuerung von haematopoetische stammzellen |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
KR20210022148A (ko) | 2007-09-28 | 2021-03-02 | 안트로제네시스 코포레이션 | 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법 |
GB0803076D0 (en) | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
KR20110050688A (ko) | 2008-08-22 | 2011-05-16 | 안트로제네시스 코포레이션 | 태반 세포 집단을 이용한 골 결함의 치료 방법 및 골 결함 치료 조성물 |
AU2009316541B2 (en) | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
EP3284818B1 (de) | 2010-01-26 | 2022-03-09 | Celularity Inc. | Behandlung von knochenbedingten karzinomen mit plazentastammzellen |
KR20230054905A (ko) | 2010-04-07 | 2023-04-25 | 셀룰래리티 인코포레이티드 | 태반 줄기 세포를 사용한 혈관신생 |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
EP2571516B1 (de) | 2010-05-18 | 2017-11-15 | Neumedicines, Inc | Formulierungen enthaltend il-12 zur erhöhung der hematopoese |
ES2666746T3 (es) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Métodos para generar linfocitos citolíticos naturales |
WO2012034070A1 (en) | 2010-09-09 | 2012-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Use of liposomal wnt compositions to enhance osseointegration |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
PL2714059T3 (pl) | 2011-06-01 | 2019-04-30 | Celularity Inc | Leczenie bólu z użyciem komórek macierzystych łożyska |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
WO2013121426A1 (en) | 2012-02-13 | 2013-08-22 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
US20180360025A1 (en) * | 2015-07-22 | 2018-12-20 | Ramot At Tel-Aviv University Ltd. | Article of manufacture and methods for increasing survival of red blood cells |
JP2020506208A (ja) * | 2017-02-10 | 2020-02-27 | ゲンマブ ビー.ブイ. | ポリペプチドバリアントおよびそれらの使用 |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE266710C (de) * | ||||
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3691016A (en) * | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) * | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4002531A (en) * | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
US4195128A (en) * | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) * | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) * | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
USRE30985E (en) * | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
FR2413974A1 (fr) * | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4229537A (en) * | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
JPS6023084B2 (ja) * | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
US4485045A (en) * | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) * | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4943529A (en) * | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4601978A (en) * | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) * | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4713339A (en) * | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) * | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4544545A (en) * | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) * | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4767704A (en) * | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
EP0206448B1 (de) * | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist |
GB8516415D0 (en) * | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4676980A (en) * | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
AU597574B2 (en) * | 1986-03-07 | 1990-06-07 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) * | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4791192A (en) * | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946783A (en) * | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
US5010182A (en) * | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) * | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
GB8724885D0 (en) * | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
EP0321196A3 (de) * | 1987-12-18 | 1990-07-18 | Mycogen Plant Science, Inc. | Transkriptionsaktivator des 780 T-DNA-Gens |
DE3889546T2 (de) * | 1987-12-21 | 1994-09-08 | Univ Toledo | Transformation von keimenden pflanzensamen mit hilfe von agrobacterium. |
AU4005289A (en) * | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
WO1990003430A1 (en) * | 1988-09-23 | 1990-04-05 | Cetus Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
ATE144281T1 (de) * | 1989-04-28 | 1996-11-15 | Rhein Biotech Proz & Prod Gmbh | Hefezellen der gattung-schwanniomyces |
FR2646437B1 (fr) * | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (de) * | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformationsvektoren für Hefe Yarrowia |
ATE144793T1 (de) * | 1989-06-29 | 1996-11-15 | Medarex Inc | Bispezifische reagenzien für die aids-therapie |
DK168302B1 (da) * | 1989-06-29 | 1994-03-07 | Danisco | Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller |
FR2649120B1 (fr) * | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
WO1991008291A2 (en) * | 1989-11-22 | 1991-06-13 | Genentech, Inc. | Latency associated peptide and uses therefor |
US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5206161A (en) * | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
WO1992020373A1 (en) * | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
WO1993008829A1 (en) * | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
US5672346A (en) * | 1992-07-27 | 1997-09-30 | Indiana University Foundation | Human stem cell compositions and methods |
CA2140280A1 (en) * | 1992-08-17 | 1994-03-03 | Avi J. Ashkenazi | Bispecific immunoadhesins |
SE9203831L (sv) * | 1992-12-18 | 1994-02-21 | Sp Wm Dricksvatten Ab | Anordning för avskiljande av emulsioner genom elektrokemisk fällning |
CA2177061A1 (en) * | 1993-12-22 | 1995-06-29 | Gideon A. Rodan | Dna encoding the wnt-x growth factor |
US5635388A (en) * | 1994-04-04 | 1997-06-03 | Genentech, Inc. | Agonist antibodies against the flk2/flt3 receptor and uses thereof |
-
1996
- 1996-08-16 US US08/696,566 patent/US5851984A/en not_active Expired - Lifetime
-
1997
- 1997-08-07 DE DE69725587T patent/DE69725587T2/de not_active Expired - Lifetime
- 1997-08-07 WO PCT/US1997/013910 patent/WO1998006747A2/en active IP Right Grant
- 1997-08-07 IL IL12812997A patent/IL128129A0/xx active IP Right Grant
- 1997-08-07 JP JP50986198A patent/JP3759623B2/ja not_active Expired - Lifetime
- 1997-08-07 ES ES97936448T patent/ES2208943T3/es not_active Expired - Lifetime
- 1997-08-07 AT AT97936448T patent/ATE252113T1/de not_active IP Right Cessation
- 1997-08-07 AU AU39112/97A patent/AU721947B2/en not_active Expired
- 1997-08-07 EP EP97936448A patent/EP0918794B1/de not_active Expired - Lifetime
-
1999
- 1999-01-19 IL IL128129A patent/IL128129A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL128129A0 (en) | 1999-11-30 |
WO1998006747A2 (en) | 1998-02-19 |
ATE252113T1 (de) | 2003-11-15 |
WO1998006747A3 (en) | 1998-05-07 |
DE69725587T2 (de) | 2004-07-29 |
EP0918794A2 (de) | 1999-06-02 |
AU721947B2 (en) | 2000-07-20 |
ES2208943T3 (es) | 2004-06-16 |
US5851984A (en) | 1998-12-22 |
AU3911297A (en) | 1998-03-06 |
JP2000516466A (ja) | 2000-12-12 |
JP3759623B2 (ja) | 2006-03-29 |
EP0918794B1 (de) | 2003-10-15 |
IL128129A (en) | 2006-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE252113T1 (de) | Verwendung von wnt polypeptiden | |
DE69527540D1 (de) | Verwendung von stammzellenfaktor und löslichen interleukin-6-rezeptor zur vermehrung der hämatopoietischen vorläuferzellen | |
AU1750297A (en) | Humanized green fluorescent protein genes and methods | |
HK1091228A1 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
WO2000053761A3 (en) | Human cytokine as ligand of the zalpha receptor and uses thereof | |
DK0772624T3 (da) | Interleukin-15 | |
AR018023A1 (es) | Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada | |
EP0559769A4 (en) | Heparin binding mitogen with homology to epidermal growth factor (egf) | |
IL148008A0 (en) | Conditional immortalisation of cells | |
IL132496A0 (en) | Mammalian cytokine-like factor 7 | |
DE69526395D1 (de) | Verwendung von Interferon-gamma zur Vermeidung der Proliferation und Differenzierung der primitiven Hämapoietischen Vorläuferzellen | |
ATE314477T1 (de) | An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung | |
ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
TR199901190T2 (xx) | Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler. | |
AU2002304249A1 (en) | Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same | |
DE69903559D1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
AU590861B2 (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
CA2262469A1 (en) | Uses for wnt polypeptides | |
ATE253634T1 (de) | Polypeptide mit serotoninerger (5ht5a) rezeptor- aktivität, für sie kodierende nukleinsäuren und ihre verwendung | |
AU1141695A (en) | Interferon-alpha/beta binding protein, its preparation and use | |
BR9407357A (pt) | Novos tripeptideos utilizáveis em terapia cns e imune | |
ATE469229T1 (de) | Herstellung von sekretierten polypeptiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |